ReviewPharmacoEconomics2019

Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma : An Evidence Review Group Evaluation of the NICE Single Technology Appraisal.

Frederick W Thielen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.